Loading...

MGX METAGENOMI THERAPEUTICS INC Contract Awards 8-K Filing

MTGN

MGX

METAGENOMI THERAPEUTICS INC

(MGX)

2024 8-K

Financial Results Update

Name Change Announcement

Financial Update

License Agreement Signed

Product Expansion

Financial Statements

Financial Results

Board Appointment

Data Presentation

Financial Results

Gene Therapy Update

External Links:

Metagenomi, Inc. announced positive data from a preclinical study on its gene editing therapy for hemophilia A, MGX-001, indicating potential durability and safety.

AI Assistant

METAGENOMI THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.